LegiPlex
AI Workspace & Legislation Tracker
New Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Videos & Transcripts
Capitol Directory
US
Oklahoma OK
Legislatures
2023 Regular Session
House
Bills
HB2107
OK
Oklahoma House Bill HB2107
Overview
Authors & Sponsors
Activity Timeline
Action History
Meeting Schedule
Draft Versions & Texts
Latest Draft
Compare Versions
Committee Assignments
Oklahoma 2023 Regular Session
Oklahoma House Bill HB2107
Introduced
2/6/23
Refer
2/7/23
Report Pass
2/15/23
Engrossed
3/13/23
Refer
3/29/23
Caption
Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date.
Latest HB2107 Activity
Companion Bills
No companion bills found.
Similar Bills
No similar bills found.